Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion description "[RAR-beta2 expression was studied by reverse transcription-polymerase chain reaction (RT-PCR) analysis in eight breast cancer cell lines that were either treated with the demethylating agent 5-aza-2'-deoxycytidine and subsequently with all-trans-retinoic acid (ATRA) or left untreated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion evidence source_evidence_literature NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion SIO_000772 10814678 NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion wasDerivedFrom befree-20150227 NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion wasGeneratedBy ECO_0000203 NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.